Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
2.150
+0.650 (43.33%)
At close: Apr 15, 2025, 4:00 PM
2.190
+0.040 (1.86%)
After-hours: Apr 15, 2025, 6:37 PM EDT
ACRV's stock price has decreased by -78.48% in the past year and price targets may not have had time to catch up.
Acrivon Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$21.80
Upside
+913.95%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +783.72% | Mar 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Mar 26, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $17 | Buy | Reiterates | $17 | +690.70% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $19 | Strong Buy | Maintains | $22 → $19 | +783.72% | Mar 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 31, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $28 → $27 | Buy | Maintains | $28 → $27 | +1,155.81% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +923.26% | Nov 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +690.70% | Sep 16, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades $16 | Hold → Strong Buy | Upgrades | $16 | +644.19% | Sep 16, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $25 → $28 | Buy | Reiterates | $25 → $28 | +1,202.33% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +923.26% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +923.26% | Aug 13, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $25 | Buy | Reiterates | $25 | +1,062.79% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | +923.26% | May 14, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 29, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $18 → $25 | Buy | Maintains | $18 → $25 | +1,062.79% | Apr 26, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.